The study by Zhang et al. (33) provided strong evidence that dyslipidemia promotes the development of DR by increased secretion of VEGF-A, VEGF-C, VEGF-D, and PlGF in patients with DR. This evidence concerns the gene VEGFD and metabolic syndrome.